Evolent Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Seth Barrie Blackley
- Full Time Employees
- 4,200
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 1812 N. Moore Street Arlington VA United States of America 22209
- IPO Date
- Jun 5, 2015
- CIK
- 0001628908
- Website
- evolent.com
- Similar Companies
- Business
- Evolent Health, Inc. (NYSE: EVH) provides specialty care management services to health plans and providers in oncology, cardiology, musculoskeletal, and primary care markets across the United States. The company offers an integrated technology platform including Identifi for data aggregation, analytics, care workflows, and patient engagement; clinical program management encompassing clinical pathways and decision support; care management services; risk adjustment; pharmacy benefits management; population health management; value-based care enablement; revenue cycle management; and advance care planning through Vital Decisions. Founded in 2011 and headquartered in Arlington, Virginia, Evolent partners with leading payers and providers to align care with clinical evidence, member preferences, and seamless delivery across settings. In September 2025, Evolent agreed to sell its accountable care organization business, Evolent Care Partners, to Privia Health for $100 million in cash plus up to $13 million contingent on 2025 Medicare Shared Savings Program performance, enabling debt reduction and a strategic focus on core specialty care management. The company announced more than $500 million in newly contracted annualized revenue set to launch in 2026 during its third quarter 2025 earnings release in November 2025, reflecting strong growth momentum. Evolent reported fiscal 2024 revenue of approximately $1.96 billion, up 17.8% year-over-year, with continued expansion in value-based care solutions.
Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming
Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH
Evolent Health Q2 Earnings Call Highlights
Evolent Health, Inc. (EVH) Q2 2026 Earnings Call Transcript
Compared to Estimates, Evolent Health (EVH) Q2 Earnings: A Look at Key Metrics
Evolent Health (EVH) Tops Q2 Earnings and Revenue Estimates
Evolent Announces Second Quarter 2026 Results
Forget Nvidia. These 5 S&P 500 stocks are quietly going all in on AI.
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Should You Buy Evolent Health (EVH) After Golden Cross?
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
Agentic AI Powers U.S. Healthcare Stocks
Evolent Health Q1 Earnings Call Highlights
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
Evolent Announces First Quarter 2026 Results
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of “Moderate Buy” by Brokerages